Early side effects include nausea, vomiting, constipation, and abdominal discomfort, typically appearing during dose escalation weeks and diminishing within days to weeks
If you have been diagnosed with diabetes, speak with your healthcare provider about switching to Mounjaro which contains the same active ingredient as Zepbound (tirzepatide) and is approved for type 2 diabetes
The TGA said it was also concerned about the unknown nature and safety of the ingredients used in manufacture
One promising medication now available is tirzepatide, an innovative therapy designed to address obesity and associated metabolic conditions
Set a 30-day check-in reminder with your provider: Ongoing provider communication is part of the program's value
Your provider must decide if the medication is appropriate and complete a prior authorization